Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Randall B. Lauffer"'
Autor:
Randall B. Lauffer
Publikováno v:
Iron and Human Disease ISBN: 9781351073899
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a9060ea05bec02dcfb793a19a24ac83
https://doi.org/10.1201/9781351073899-20
https://doi.org/10.1201/9781351073899-20
Autor:
Marga Spiller, Normand J. Cloutier, Randall B. Lauffer, Peter Caravan, Thomas J. Mcmurry, Jeffrey J. Ellison, Jaclyn M. Chasse, Claudio Luchinat, Giacomo Parigi, Sarah A. McDermid
Publikováno v:
Inorganic Chemistry. 46:6632-6639
The amphiphilic gadolinium complex MS-325 ((trisodium-{(2-(R)-[(4,4-diphenylcyclohexyl) phosphonooxymethyl] diethylenetriaminepentaacetato) (aquo)gadolinium(III)}) is a contrast agent for magnetic resonance angiography (MRA). MS-325 consists of two s
Autor:
Randall B. Lauffer, Thomas J. McMurry, Zhaoda Zhang, Marga Spiller, Matthew T. Greenfield, Peter Caravan
Publikováno v:
Angewandte Chemie International Edition. 44:6766-6769
Autor:
Sarah A. McDermid, John C. Amedio, Matthew T. Greenfield, Arnold M. Raitsimring, Peter Caravan, Marga Spiller, Normand J. Cloutier, Randall B. Lauffer, Thomas J. McMurry, Stephen U. Dunham, Stephan G. Zech, Richard J. Looby
Publikováno v:
Chemistry - A European Journal. 11:5866-5874
The synthesis of a novel ligand, based on N-methyl-diethylenetriaminetetraacetate and containing a diphenylcyclohexyl serum albumin binding group (L1) is described and the coordination chemistry and biophysical properties of its Gd(III) complex Gd-L1
Autor:
Andrea J. Wiethoff, Randall B. Lauffer, Philip B. Graham, Rolf W. Günther, Edward C. Parsons, Elmar Spuentrup, Robert M. Weisskoff, Warren J. Manning, René M. Botnar, Marcus Katoh, Arno Buecker, George Katsimaglis
Publikováno v:
Circulation. 110:1463-1466
Background— The advent of fibrin-binding molecular magnetic resonance (MR) contrast agents and advances in coronary MRI techniques offers the potential for direct imaging of coronary thrombosis. We tested the feasibility of this approach using a ga
Autor:
Ronald M. Supkowski, William DeW. Horrocks, Richard J. Looby, Thomas J. McMurry, Randall B. Lauffer, Jeff W.M. Bulte, John C. Amedio, Sarah A. McDermid, Normand J. Cloutier, Matthew T. Greenfield, Peter Caravan, Stephen U. Dunham
Publikováno v:
Journal of the American Chemical Society. 124:3152-3162
MS-325 is a novel blood pool contrast agent for magnetic resonance imaging currently undergoing clinical trials to assess blockage in arteries. MS-325 functions by binding to human serum albumin (HSA) in plasma. Binding to HSA serves to prolong plasm
Autor:
Alexander Nivorozhkin, Peter Caravan, Andrew Kolodziej, Matthew T. Greenfield, Randall B. Lauffer, Thomas J. McMurry
Publikováno v:
Angewandte Chemie. 113:2987-2990
Clinically relevant relaxivity enhancement of a magnetic resonance imaging (MRI) contrast agent has been achieved by using prodrug Gd3+ complexes (see picture, DTPA=diethylenetriaminepentaaceto). Enzymatic cleavage of lysine residues from the prodrug
Autor:
Mark B.M. Hofman, Samuel A. Wickline, Randall B. Lauffer, Stefan Fischer, Kofi Adzamli, Sándor J. Kovács, Robert E. Henson, Jan De Becker, Christine H. Lorenz
Publikováno v:
Magnetic Resonance in Medicine. 41:360-367
The ability of a blood pool contrast agent to enhance MR coronary angiography was defined. The proximal coronary vessels of pigs were imaged before and after administration of Gd-DTPA bound covalently to bovine serum albumin (0.2 mmol/kg). The contra
Publikováno v:
ChemInform. 30
A. Water Exchange 2326 B. Proton Exchange 2327 C. Electronic Relaxation 2327 D. Relaxivity 2331 E. Outerand Second-Sphere Relaxivity 2334 F. Methods of Improving Relaxivity 2336 V. Macromolecular Conjugates 2336 A. Introduction 2336 B. General Conjug
Publikováno v:
Magnetic Resonance in Medicine. 17:164-178
Binding of potential blood pool and hepatobiliary paramagnetic iron(III) contrast agents, rac- and meso-Fe(5-Br-EHPG)- (iron(III) N,N'-ethylenebis [(5-bromo-2-hydroxyphenyl)glycinate]) and Fe(5-Br-HBED)- (iron(III) N,N'-bis-(5-bromo-2-hydroxybenzyl)e